Grantham, Mayo, Van Otterloo & Co (GMO)
OGN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Organon & Co OGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-448,874
Closed -$2.69M – 706
2026
Q1 		$2.69M Buy
448,874
+1,213
+0.3% +$9.13K 0.01% 404
2025
Q4 		$3.21M Sell
447,661
-46,386
-9% -$366K 0.01% 366
2025
Q3 		$5.28M Sell
494,047
-31,088
-6% -$305K 0.01% 287
2025
Q2 		$5.08M Buy
525,135
+108,429
+26% +$1.12M 0.02% 292
2025
Q1 		$6.2M Buy
+416,706
New +$6.41M 0.02% 284
2024
Q4 		– Sell
-28,646
Closed -$548K – 600
2024
Q3 		$548K Buy
28,646
+6,941
+32% +$144K ﹤0.01% 484
2024
Q2 		$449K Sell
21,705
-8,690
-29% -$173K ﹤0.01% 456
2024
Q1 		$571K Buy
30,395
+10,148
+50% +$174K ﹤0.01% 431
2023
Q4 		$292K Buy
+20,247
New +$275K ﹤0.01% 446
2021
Q4 		– Sell
-295,309
Closed -$9.68M – 721
2021
Q3 		$9.68M Sell
295,309
-20,153
-6% -$645K 0.05% 253
2021
Q2 		$9.55M Buy
+315,462
New +$10.4M 0.05% 254

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s OGN Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 448,874 shares — an estimated $2.69M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $9.68M in Q3 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 448,874 Organon & Co shares in Q2 2026, an estimated $2.69M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Organon & Co position peaked at $9.68M in Q3 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.